Rob Higgins
Overview
Explore the profile of Rob Higgins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Higgins R, Lowe D, Hathaway M, Lam F, Kashi H, Tan L, et al.
Ther Apher Dial
. 2010 Jul;
14(4):392-9.
PMID: 20649760
Double filtration plasmapheresis (DFPP) was used in preference to plasma exchange in our program of antibody-incompatible transplantation, to treat higher volumes of plasma. Forty-two patients had 259 sessions of DFPP,...
12.
Hamer R, Roche L, Smillie D, Harmer A, Mitchell D, Molostvov G, et al.
Transpl Immunol
. 2010 Jul;
23(4):161-5.
PMID: 20600903
HLA antibody-incompatible transplantation has a higher risk of rejection when compared to standard renal transplantation. Soluble CD30 (sCD30) has been shown in many, but not all, studies to be a...
13.
Higgins R, Zehnder D, Chen K, Lowe D, McKinnell J, Lam F, et al.
Nephrol Dial Transplant
. 2009 Nov;
25(4):1306-12.
PMID: 19934085
Background: The aim of this study was to examine the development of acute antibody-mediated rejection in HLA antibody-incompatible renal transplantation in relation to the Banff 07 histological classification. Methods: Renal...
14.
Jain P, Cockwell P, Little J, Ferring M, Nicholas J, Richards N, et al.
Nephrol Dial Transplant
. 2009 Sep;
24(12):3840-6.
PMID: 19755474
Introduction: Accurate assessment of determinants of patient survival in end-stage renal disease is important for counselling, clinical management and resource planning. To address this we have analysed survival and risk...
15.
Higgins R, Mitchell D
Transplantation
. 2009 Jul;
88(2):149-50.
PMID: 19623008
No abstract available.
16.
Higgins R, Lowe D, Hathaway M, Lam F, Kashi H, Tan L, et al.
Transplantation
. 2009 Mar;
87(6):882-8.
PMID: 19300192
Background: After human leukocyte antigen (HLA) antibody-incompatible transplantation, donor specific and third party HLA antibodies may be found, and their levels fall in a donor-specific manner during the first month....
17.
Higgins R, Hathaway M, Lowe D, Zehnder D, Krishnan N, Hamer R, et al.
J Ren Care
. 2008 May;
34(2):85-93.
PMID: 18498573
Antibodies in the blood of a kidney transplant recipient can provide a barrier to transplantation, which is additional to the usual possibility of cellular rejection. The antibodies most frequently encountered...
18.
Higgins R, Hathaway M, Lowe D, Lam F, Kashi H, Tan L, et al.
Transplantation
. 2007 Nov;
84(7):876-84.
PMID: 17984841
Background: Accommodation to antibody is an important mechanism in successful ABO-incompatible transplantation, but its importance in human leukocyte antigen (HLA) antibody-incompatible transplantation is less clear, as sensitive techniques facilitating daily...
19.
20.
Higgins R, West N, Fletcher S, Stein A, Lam F, Kashi H
Nephrol Dial Transplant
. 2003 Mar;
18(4):851-2.
PMID: 12637669
No abstract available.